C. auris, first identified in 2009 in Asia, has quickly become a cause of severe infections around the world. C. auris is a concerning drug-resistant fungus. It can cause outbreak in healthcare fa...
Meet Genobio at ISHAM 2022
The 21st Congress of the International Society for Human and Animal Mycology (ISHAM) will be held in New Delhi, India on 20-24 September 2022.
ISHAM is a worldwide o...
Genobio Successfully Approved by Health Canada for its Aspergillus Rapid Test
Tianjin, China – September 14, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, ...
Tianjin, China – April 21, 2022 – Tianjin Era Biology Technology Co., Ltd is please to announce that Era Biology obtained registration certificates for all seven Carbapenem-resistant Detection K-Se...
Tianjin, China – July 28, 2022 – Genobio Pharmaceutical Co., Ltd, a wholly-owned subsidiary of Era Biology Group, which is a leader and pioneer of invasive fungal disease diagnostic field since 199...
These series of methods are assays by utilizing specific viral antigen to detect antibodies in patients’ serum, including IgM antibodies detection and IgG antibodies measurement. The IgM antibodies...